Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD

Respiratory Medicine

Volumn 101, Issue 6, 2007, Pages 1338-1343

  Domagała Kulawik, Joanna ^a   Hoser, Grazyna ^b   Dabrowska, Marta ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Apoptosis; CD8+ cells; COPD; Fas; Lymphocytes; Smoking

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; MONOCLONAL ANTIBODY;

ADULT; AGED; AIRWAY OBSTRUCTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOXEMIA; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; T-LYMPHOCYTE SUBSETS; VITAL CAPACITY;

EID: 34247564631     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.10.004     Document Type: Article

References (23)

1. Celli B.R., and Mac Nee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
2. Barnes P.J., Shapiro S.D., and Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22 (2003) 672-688
3. Saetta M., Turato G., Maestrelli P., Mapp C.E., and Fabbri L.M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1304-1309
4. Oudijk E.J., Lammers J.W., and Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 46 (2003) 5s-13s
5. Kim W.D., Kim W.S., et al. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 122 2 (2002) 437-444
6. de Jong J., Belt-Gritter B., Koeter G.H., and Postma D.S. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking IgE and lung function. Respir Med 91 (1997) 67-76
7. 1 in smokers. Respir Med 100 6 (2006) 1088-1093
8. Kawiak J., Hoser G., and Skorski T. Apoptosis and some of its medical implications. Folia Histochem Cytobiol 36 3 (1998) 99-110
9. Tollerud D.J., Clark J.W., et al. The effects of cigarette smoking on T cell subsets A population-based survey of healthy Caucasians. Am Rev Respir Dis 139 (1989) 1446-1451
10. Costabel U., Bross K.J., Reuter C., Ruhle K.H., and Matthys H. Alterations in immunoregulatory T-cell subsets in cigarette smokers A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 90 (1986) 39-44
11. Domagala- Kulawik J., Maskey- Warzechowska M., Kraszewska I., and Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 123 (2003) 1054-1059
12. Varadhachary A.S., and Salgame P. CD95 mediated T cell apoptosis and its relevance to immune deviation. Oncogene 17 (1998) 3271-3276
13. Hodge S.J., Hodge G.L., Reynolds P.N., Scicchitano R., and Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 285 (2003) L492-L499
14. Yasuda N., Gotoh K., Minatoguchi S., et al. An increase of soluble Fas an inhibitor of apoptosis associated with progression of COPD. Respir Med 92 (1998) 993-999
15. Piazza C M., Gilardini S., Montani S., Moretti S., Cundari E., and Piccolella E. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis. J Immunol 158 (1997) 1503-1506
16. Tateyama M., Oyaizu N., McCloskey T.W., Than S., and Pahwa S. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood 96 (2000) 195-202
17. Di Stefano A., Caramori G., Capelli, et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 78-85
18. Majo J., Ghezzo H., and Cosio M.G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 17 (2001) 946-953
19. Sullivan A K., Simonian P.L., Falta M.T., et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 172 (2005) 590-596
20. Hoser G., Wasilewska D., and Domagala- Kulawik J. Expression of Fas receptor on peripheral blood lymphocytes from patients with non-small cell lung cancer. Folia Histochem Cytobiol 42 (2004) 249-252
21. Domagala- Kulawik J., Hoser G., Droszcz P., Kawiak J., Droszcz W., and Chazan R. T-cell subtypes in bronchoalveolar lavage fluid and in peripheral blood from patients with primary lung cancer. Diagn Cytopathol 25 (2001) 208-213
22. Kim S., and Nadel J.A. Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treat Respir Med 3 (2004) 147-159
23. Bijl M., Horst G., Limburg P.C., and Kallenberg C.G. Effects of smoking on activation markers Fas expression and apoptosis of peripheral blood lymphocytes. Eur J Clin Invest 31 (2001) 550-553